2024update
Home page update 20241101
FFAF5D43-CAF2-4987-AC15-6472095C7509.jpg
https://ccr.kmu.edu.tw/images/Homepage_2024update/FFAF5D43-CAF2-4987-AC15-6472095C7509.jpg
6843B52C-1CA6-4B5D-A207-833C8012F548.jpg
https://ccr.kmu.edu.tw/images/Homepage_2024update/6843B52C-1CA6-4B5D-A207-833C8012F548.jpg
113-09-12-C-4.jpg
https://ccr.kmu.edu.tw/images/Homepage_2024update/113-09-12-C-4.jpg
S__13434993.jpg
https://ccr.kmu.edu.tw/images/Homepage_2024update/S__13434993.jpg
__1.jpg
__2.jpg
課程目標:
癌症已經長達三十餘年蟬聯國人十大死因之首,造成家庭與國家重大損失,也是目前醫學上仍未解的難題,而隨著癌症治療的進步,抗癌的選擇更為多元化,也逐漸趨於「精準醫療」。直至今日,許多癌症已被證實與異常的基因表現或是分子傳遞路徑的有關,因此標靶治療的發展就應運而生。然許多標靶藥物在病人血中藥物濃度與療效和/或毒性具相關性,當以建議劑量對不同病人族群表現高度變異性,因此藥物動力學與藥效學在臨床之應用更加重要,同時藉由精準癌症治療已在各國臨床試験及研究論文大量發表之際,如何利用系統性回顧及統合分析之實作以做為實證藥學發展之重要依據。本課程導入癌細胞進程、癌症診斷與治療發展、精準醫療、實證藥學等主題,由醫學院、藥學院教師,以及外聘教師講授,期盼培育研究生具備在精準癌症治療與臨床藥學之關鍵知識,助於未來從事癌症相關之臨床醫學、藥學科學、臨床藥學研究工作。
開課時間:113年09月14日至113年12月07日
參加對象:本校碩士班、碩士在職專班學生
課程負責人:吳育澤 教授
參與人員:洪仁宇 教授、劉校生 教授、吳宜珍 教授、王照元 教授兼院長、葉宗讓 醫師、黃耀斌 教授、吳育澤 教授、張值維 助理教授、陳崇鈺 教授、洪瑄佑 講師、王詩瑋講師、吳承誌講師
聯絡窗口:張值維 助理教授
連絡電話:07-3121101#2653
113年度深耕計畫 課程報名:https://reurl.cc/NQ6rVx
研發處深耕計畫人才培育課程系列研習營 公告網頁:https://reurl.cc/z1ze9y
※ 課程海報最新更新日期: 2024/8/30
Course Objectives:
Cancer has ranked among the top ten causes of death for more than thirty years, causing significant losses to families and countries. It remains an unresolved challenge in medicine. With advances in cancer treatment, the choices for cancer treatment have become more diversified, gradually moving towards 'precision medicine.' To this day, many cancers have been confirmed to be related to abnormal gene expression or molecular pathways, leading to the emergence of targeted therapies. However, many targeted drugs show a correlation between drug concentration in the patients' blood, efficacy, and/or toxicity. Since recommended doses exhibit high variability among different patient populations, pharmacokinetics and pharmacodynamics become even more critical in clinical practice. By utilizing systematic reviews and integrated analysis as the foundation for evidence-based pharmacology development, how to apply precision cancer treatment has been extensively discussed in clinical trials and research papers worldwide. This course covers topics such as cancer cell progression, cancer diagnosis and treatment development, precision medicine, and evidence-based pharmacology, taught by faculty from the medical and pharmaceutical schools as well as guest lecturers. It aims to equip graduate students with key knowledge in precision cancer treatment and clinical pharmacology to engage in future clinical medicine, pharmaceutical science, and clinical pharmacology research related to cancer.
Course Schedule: September 14 to December 07, 2024
Participants: Students of the Master's Program and On-the-Job Master´s Program
Course Director: Professor Yu-Tse Wu
Participants:
Professor Jen-Yu Hung, Professor Hsiao-Sheng Liu, Professor I-Chen Wu, Professor Jaw-Yuan Wang, Dr. Tsung-Jang Yeh, Professor Yaw-Bin Huang, Professor Yu-Tse Wu, Assistant Professor Chih-Wei Chang, Professor Chung-Yu Chen, Lecturer Hsuan-Yu Hung, Lecturer Shih-Wei Wang, Lecturer Cheng-Zhi Wu
Contact Person: Chih-Wei Chang, Assistant Professor
Contact Number: 07-3121101#2653
Course registration : https://reurl.cc/NQ6rVx
Announcement Page of Office of Research and Development of KMU: https://reurl.cc/z1ze9y